Literature DB >> 19072882

A prior myocardial infarction: how does it affect management and outcomes in recurrent acute coronary syndromes?

Apurva A Motivala1, Umesh Tamhane, Vijay S Ramanath, Fadi Saab, Daniel G Montgomery, Jianming Fang, Eva Kline-Rogers, Niquole May, Garry Ng, James Froehlich, Hitinder Gurm, Kim A Eagle.   

Abstract

BACKGROUND: Despite improved secondary prevention efforts, acute coronary syndrome (ACS) recurrence among patients with prior history of coronary events remains high. The differences in presentation, management, and subsequent clinical outcomes in patients with and without a prior myocardial infarction (MI) and presenting with another episode of ACS remain unexplored.
METHODS: A total of 3,624 consecutive patients admitted to the University of Michigan with ACS from January 1999 to June 2006 were studied retrospectively. In-hospital management, outcomes, and postdischarge outcomes such as death, stroke, and reinfarction in patients with and without a prior MI were compared.
RESULTS: Patients with a prior MI were more likely to be older and have a higher incidence of diabetes mellitus, hypertension, hyperlipidemia, and peripheral vascular disease. In-hospital outcomes were not significantly different in the 2 groups, except for a higher incidence of cardiac arrest (4.3% versus 2.5%, p < 0.01) and cardiogenic shock (5.7% versus 3.9%, p = 0.01) among patients without a prior MI. However, at 6 mo postdischarge, the incidences of death (8.0% versus 4.5%, p < 0.0001) and recurrent MI (10.0% versus 5.1%, p < 0.0001) were significantly higher in patients with a prior history of MI compared with those without.
CONCLUSION: Patients with prior MI with recurrent ACS remain at a higher risk of major adverse events on follow-up. This may be partly explained by the patients not being on optimal medications at presentation, as well as disease progression. Increased efforts must be directed at prevention of recurrent ACS, as well as further risk stratification of these patients to improve their overall outcomes. (c) 2008 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 19072882      PMCID: PMC6653472          DOI: 10.1002/clc.20356

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  12 in total

1.  Heterogeneity in MT1-MMP activity with ischemia-reperfusion and previous myocardial infarction: relation to regional myocardial function.

Authors:  Jennifer A Dixon; William F Gaillard; William T Rivers; Christine N Koval; Robert E Stroud; Rupak Mukherjee; Francis G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-08       Impact factor: 4.733

2.  Predictors and in-hospital prognosis of recurrent acute myocardial infarction.

Authors:  Cheng-Fu Cao; Su-Fang Li; Hong Chen; Jun-Xian Song
Journal:  J Geriatr Cardiol       Date:  2016-10       Impact factor: 3.327

Review 3.  The Contribution of Individual Exercise Training Components to Clinical Outcomes in Randomised Controlled Trials of Cardiac Rehabilitation: A Systematic Review and Meta-regression.

Authors:  Bridget Abell; Paul Glasziou; Tammy Hoffmann
Journal:  Sports Med Open       Date:  2017-05-05

4.  Impact of combination therapy with statin and ezetimibe on secondary prevention for post-acute myocardial infarction patients in the statin era.

Authors:  Soichiro Ebisawa; Atsushi Izawa; Yasushi Ueki; Hirofumi Hioki; Masatoshi Minamisawa; Naoto Hashizume; Naoyuki Abe; Yuichiro Kashima; Takashi Miura; Takahiro Takeuchi; Hirohiko Motoki; Ayako Okada; Yusuke Miyashita; Jun Koyama; Uichi Ikeda
Journal:  Int J Cardiol Heart Vasc       Date:  2015-08-01

5.  Statin Utilization Patterns and Outcomes for Patients with Acute Coronary Syndrome During and Following Inpatient Admissions.

Authors:  Susan H Boklage; Elisabetta Malangone-Monaco; Lorena Lopez-Gonzalez; Yao Ding; Caroline Henriques; Joseph Elassal
Journal:  Cardiovasc Drugs Ther       Date:  2018-06       Impact factor: 3.727

6.  Impact of chronic total occlusion lesion length on six-month angiographic and 2-year clinical outcomes.

Authors:  Jihun Ahn; Seung-Woon Rha; ByoungGeol Choi; Se Yeon Choi; Jae Kyeong Byun; Ahmed Mashaly; Kareem Abdelshafi; Yoonjee Park; Won Young Jang; Woohyeun Kim; Jah Yeon Choi; EunJin Park; Jin Oh Na; Cheol Ung Choi; EungJu Kim; Chang Gyu Park; Hong Seog Seo; Dong Joo Oh; JinSu Byeon; SangHo Park; HyeYon Yu
Journal:  PLoS One       Date:  2018-11-13       Impact factor: 3.240

7.  Lipid-Lowering Efficacy of Ezetimibe in Patients with Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analyses.

Authors:  Fadia Tohme Shaya; Krystal Sing; Robert Milam; Fasahath Husain; Michael A Del Aguila; Miraj Y Patel
Journal:  Am J Cardiovasc Drugs       Date:  2020-06       Impact factor: 3.571

8.  Secular Decreasing Trend in Plasma Eicosapentaenoic and Docosahexaenoic Acids among Patients with Acute Coronary Syndrome from 2011 to 2019: A Single Center Descriptive Study.

Authors:  Tomoaki Okada; Toru Miyoshi; Masayuki Doi; Kosuke Seiyama; Wataru Takagi; Masahiro Sogo; Kazumasa Nosaka; Masahiko Takahashi; Keisuke Okawa; Hiroshi Ito
Journal:  Nutrients       Date:  2021-01-17       Impact factor: 5.717

9.  Psychological distress in spouses of somatically Ill: longitudinal findings from the Nord-Trøndelag Health Study (HUNT).

Authors:  Ingrid Borren; Kristian Tambs; Kristin Gustavson; Jon Martin Sundet
Journal:  Health Qual Life Outcomes       Date:  2014-09-09       Impact factor: 3.186

10.  When More Means Less: The Prognosis of Recurrent Acute Myocardial Infarctions.

Authors:  Ygal Plakht; Harel Gilutz; Arthur Shiyovich
Journal:  J Clin Med       Date:  2021-12-15       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.